Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro

Respiratory Medicine

Volumn 91, Issue 3, 1997, Pages 159-168

  Gillissen, A ^a   Jaworska, M ^a   Orth, M ^a   Coffiner, M ^b   Maes, P ^b   App, E M ^c   Cantin, A M ^d   Schultze Werninghaus, G ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Laboratories SMB and Galephar   (Belgium)

^c UNIVERSITY OF MUNICH   (Germany)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLCYSTEINE DERIVATIVE; AMBROXOL; ANTIOXIDANT; BUTHIONINE SULFOXIMINE; GLUTATHIONE; HYDROGEN PEROXIDE; LYSINE DERIVATIVE; NACYSTELYN; OXYGEN RADICAL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING;

EID: 0030902329     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90052-4     Document Type: Article

References (48)

1. Schraufstätter IU, Cochrane CG. Oxidants: types, sources, and mechanisms of injury. In: Crystal RG, West JB, eds. The Lung, Scientific Foundations. New York: Raven Press, 1991; 1803-1810.
2. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991; 91: 3C-14S-3C-22S.
3. Cantin AM, North GA, Fells RC et al. Oxidant mediated epithelial cell injury in pulmonary fibrosis. J Clin Invest 1987; 79: 1665-1673.
4. Meyer A, Buhl R, Magnussen H. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 1994; 7: 431-436.
5. Church DF, Pryor WA. The oxidative stress placed on the lung by cigarette smoke. In: Crystal RG, West JB, eds. The Lung Scientific Foundation. New York: Raven Press, 1991; 1975-1979.
6. Cochrane CG. Cellular injury by oxidants. Am J Med 1991; 91: 3C-23S-3C-30S.
7. Heffner JE, Repine JE. Antioxidants in the lung. In: Crystal RG, West JB, eds. The Lung Scientific Foundation. New York: Raven Press, 1991; 1811-1820.
8. Jenkinson SG. Free radical effects on lung metabolism. Clin Chest Med 1989; 10: 37-47.
9. Borok Z, Buhl R, Grimes GJ et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338: 215-216.
10. Gillissen A, Roum JH, Hoyt RF et al. Augmentation of respiratory epithelial lining fluid anti-oxidant screen by aerosolization of recombinant human Cu++/Zn++ Superoxide dismutase. Chest 1993; 104: 811-815.
11. Prescott LF, Donovan JW, Jarvie DR et al. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37: 501-506.
12. Flanagan RJ. The role of acetylcysteine in clinical toxicology. Med Toxicol 1987; 2: 93-104.
13. Buhl R, Vogelmeier C, Crittenden M et al. Augmentation of reduced glutathione levels in the epithelial lining fluid of the lower respiratory tract by direct aerosol administration of glutathione. Proc Nat Acad Sci 1990; 87: 4063-4067.
14. Meister A. Selective modification of lutathione metabolism. Science 1983; 220: 472-477.
15. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988; 262: 17205-17208.
16. Tsan M-F, White JE, Rosan CL. Modulation of endothelial GSH concentrations effect of exogenous GSH and GSH monoethylester. J Appl Physiol 1989; 66: 1029-1034.
17. Jurima-Romet M, Barber RF, Demeester J et al. Distribution studies of liposome-encapsulated glutathione administered to the lung. Int J Pharmaceutics 1990; 63: 227-235.
18. Bridgeman MME, Marsden M, Selby C et al. Effect of N-acetylcysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 1994; 49: 670-675.
19. Gillissen A, Birrer P, Buhl R et al. Recombinant secretory leukoprotease inhibitor augments glutathione levels in respiratory epithelial lining fluid. J Appl Physiol 1993; 75: 825-832.
20. Cotgreave I, Moldéus P, Schuppe I. The metabolism of N-acetylcysteine by human endothelial cells. Biochem Pharmacol 1991; 42: 13-16.
21. App EM, Hochstrasser K, Tomkiewicz RP et al. Do SH-group carrying reducing agents affect the protease-antiprotease balance in bronchial secretions ? Eur Respir J 1993; 6: 438s.
22. App EM, Tomkiewicz RP, Hochstrasser K et al. Thio-group carrying mucolytic agents inactivate proteases such as human neutrophil elastase (HNE) in vitro. Am Rev Respir Dis 1993; 4: A673.
23. Hardy JG, Everard ML, Coffiner M et al. Lung desposition of a Nacystelyn metered dose inhaler formulation. J Aerosol Med 1993; 6: 37-44.
24. Marriott C, Ingham S, Coffiner M et al. Determination of the mode of action of a novel mucolytic agent, nacystelyn. Eur Respir J 1993; 6: 438s.
25. Bibi H, Seifert B, Oullette M et al. Intratracheal N-acetylcysteine use in infants with chronic lung disease. Acta Paediatr 1992; 81: 335-339.
26. Ventresca GP, Cicchetti V, Ferrari V. Acetylcysteine. In: Braga PC, Allegra L, eds. Drugs in Bronchial Mucology. New York: Raven Press, 1989; 77-102.
27. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969; 27: 502-522.
28. Aruoma OI, Halliwell B, Hoey BM et al The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxylradical, superoxide, and hypochlorus acid. Free Rad Biol Med 1989; 6: 593-597.
29. Crapo JD, McCord JM, Fridovich I. Preparation and assay of superoxide dismutase. In: Fleischer S, Packer L, eds. Methods in Enzymology, Biomembranes, part D: Biological Oxidations Mitochondrial and Microbial Systems. New York: Academic Press, 1978; 382-393.
30. Yamada T, Volkmer C, Grisham MB. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. Free Rad Biol Med 1991; 10: 41-49.
31. Gillissen A, Jaworska M, Schärling B et al. Eine einfache Reinigungsmethode für granulo- und monozytäre Zellen am Beispiel der Glutathionbestimmung in Serum und Zellen bei Patienten mit einer COPD. Atemw-Lungenkrkh 1994; 20: 308-309.
32. Anderson R, Theron AJ, Richards GA et al. Passive smoking by humans sensitizes circulating neutrophils. Am Rev Respir Dis 1991; 144: 570-574.
33. Kondo T, Tagami S, Yoshioka A et al. Current smoking of elderly men reduces antioxidants in alveolar macrophages. Am J Respir Crit Care Med 1994; 149: 178-182.
34. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Meth 1980; 38: 161-170.
35. Cantin AM, Larivée P, Begin RO. Extracellular glutathione suppresses human lung fibroblasts proliferation. Am J Respir Cell Mol Biol 1990; 3: 79-85.
36. Cantin A, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989; 139: 370-372.
37. Suter PM, Domenighetti G, Schaller M-D et al. N-acetylcysteine enhances recovery from acute lung injury in man. Chest 1994; 105: 190-194.
38. 2 toxicity by N-acetylcysteine. Eur Respir J 1989; 2: 116-126.
39. Meyer A, Buhl R, Kampf S et al. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995; 152: 1055-1060.
40. de Quay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992; 6: 815-819.
41. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacol Ther 1991; 51: 155-194.
42. Eklund A, Eriksson O, Hakansson L et al. Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. Eur Respir J 1988; 1: 832-838.
43. Weinander R, Anderson C, Morgenstern R. Identification of N-acetylcysteine as a new substrate for rat liver microsomal glutathione transferase. J Biol Chem 1994; 269: 71-76.
44. Deutscher Apotheker Verlag. Monographie Lysin-Monohydrat. In: German Pharmacopoeia. Frankfurt/Eschborn: Govi Verlag GmbH, 1996.
45. Phelps DT, Deneke SM, Daley DL et al. Elevation of glutathione levels in bovine pulmonary artery endothelial cells by N-acetylcysteine. Am J Respir Cell Mol Biol 1992; 7: 293-299.
46. Cotgreave IA, Berggren M, Jones TW et al. Gastrointestinal metabolism of N-acetyl cysteine in the rat, including an assay for sulfite in biological systems. Biopharm Drug Dispos 1987; 8: 377-386.
47. Sheffner AL, Medler EM, Bailey KR et al. Metabolic studies with N-acetyl cysteine. Biochem Pharmacol 1966; 15: 1523-1535.
48. Morris AH, Kanner RE, Crapo RO et al. Clinical Pulmonary Function Testing: a Manual of Uniform Laboratory Procedures, 2nd edn. Salt Lake City, UT: Intermountain Thoracic Society (ITS), 1984.